HC upholds order stopping 28 drugmakers to produce antibiotics, cancer drugs
Staff Correspondent, bdnews24.com
Published: 2017-04-03 15:17:43.0 BdST Updated: 2017-04-03 15:36:38.0 BdST
The High Court has upheld a previous order instructing 28 pharmaceutical companies to stop production of antibiotics, steroids and cancer drugs.
On Monday, Justice Syed Muhammad Dastagir Husain and Justice Md Ataur Rahman Khan passed the order after a hearing was held over a rule issued in February.
After initial hearing of a petition on Feb 27, the court gave the drugmakers three days to stop production of antibiotics, steroids and cancer medicines.
It had also issued a rule asking why these companies’ operations will not be declared illegal.
Secretaries to the ministries of health and industry, chiefs of the health directorate and consumer rights protection directorate and four others were instructed to come up with explanations.
On Monday, the High Court disposed of the matter and upheld its order stopping manufacturing by the 28 companies.
The 28 companies
Amico Pharma, Aztec Pharmaceuticals, Bengal Techno Pharma Ltd, Benham Pharmaceuticals, Central Pharmaceuticals, Descent Pharma, Dr. Tims Pharmaceuticals, Globex Pharmaceuticals, Greenland Pharmaceuticals, Inova Pharmaceuticals, Max Drugs Ltd, Medi Mate Laboratories, Modern Pharmaceuticals, Mystic Pharmaceuticals, National Laboratories, Organic Health Care Ltd, Wester Pharma, Premier Pharmaceuticals, Prime Pharmaceuticals, Seema Pharmaceuticals, White Horse Pharmaceuticals, Momtaz Pharmaceuticals, Unique Pharmaceuticals, United Chemicals and Pharmaceuticals, FNF Pharmaceuticals, Techo Drugs Ltd's Units 1,2 and 3.
Rights body Human Rights and Peace for Bangladesh moved the High Court with a petition as the authorities did not take any step despite a special panel, formed upon the permission of the Speaker, recommended stopping these companies from producing drugs.
The petition said the 28 companies have been manufacturing antibiotics, steroids and cancer drugs without following the World Health Organization's Good Manufacturing Practice (GMP), posing a major risk to public health.
The GMP ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the product specification.
Any unauthorised use or reproduction of bdnews24.com content for commercial purposes is strictly prohibited and constitutes copyright infringement liable to legal action.
- Social taboo, shyness keep Bangladesh’s adolescents away from health corners: Population Council
- Bangladeshis are largest foreign takers of Indian health services: Report
- Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018
- Beware of dengue, chikungunya in intermittent rains
- Bangladesh to introduce rota virus, HPV vaccines in 2018
- Bangladesh devises plan to eliminate malaria by 2030
- Understanding autism may open door to possibilities: Prof Stephen Shore
- Novo Nordisk, Leo Club support 11 intellectually disabled children’s education
- WHO South-East Asia adopts Thimphu Declaration, pledges inclusive approaches for autism
- French regulator says up to 4,100 children victims of epilepsy drug
- Pakistan journalist Hamid Mir 'will return' his father's 1971 award to Bangladesh
- Bangladesh Islamist groups plan new alliances for next election
- Housewife bites off alleged rapist's tongue in Feni
- 'Operation Eagle Hunt' on: Final appeal to militants to surrender
- Cameron ‘proud’ of Bangladesh, says ‘sorry’ for not visiting as prime minister
- Five-year-old Sumaiya speaks about her 'abduction'
- Hillary Clinton’s aides threatened me with tax audit: Sajeeb Wazed Joy
- United Airlines reaches settlement with passenger dragged from plane
- Chapainawabganj terror den: 3 bodies 'too mangled' for identification
- Oxford Union invites President Hamid but gets no response